Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Cancer Immunology and Immunotherapy

ESMO scientific and educational resources on this topic
Recent medwireNews and resources from conferences are for ESMO Members only.

Find future ESMO meetings in the Oncology Calendar

Check future Preceptorship courses on this topic

ESMO Journal

Immuno-Oncology and Technology

How To video

How to manage toxicities from Immune Checkpoint Inhibitors?

Latest ESMO videos

Expert Report on advances in the management of HER2-negative and HER2-low advanced breast cancer from ASCO 2022

20 Jun 2022

Expert Report on novel data in (neo)adjuvant treatment of melanoma from ASCO 2022

20 Jun 2022

Expert Report on novelties in the management of gynaecological malignancies from ASCO 2022

17 Jun 2022

Expert Video Report on featured outcomes from novel NSCLC trials - AACR 2022

25 Apr 2022

Highlights on CAR T cells in advanced solid tumours - AACR 2022

25 Apr 2022

Watch all ESMO videos

Featured medwireNews

30 Jun 2022

Anticancer Agents; Hepatobiliary Cancers; Immunotherapy

Durvalumab Biliary Tract Cancer Benefit Observed Regardless Of Primary Tumour Location

29 Jun 2022

Clinical Research; Immunotherapy

Botensilimab–Balstilimab Combination Shows Activity For Microsatellite Stable, Metastatic CRC

05 May 2022

Breast Cancer; Clinical Research; Immunotherapy

BEGONIA: Dato-DXd Plus Durvalumab Achieves ‘Robust Response’ In Advanced TNBC

04 May 2022

Breast Cancer; Clinical Research; Immunotherapy

HER3-DXd Induces CelTIL Increase In Early-Stage HR-Positive, HER2-Negative Breast Cancer

13 Apr 2022

Clinical Research; Immunotherapy; Non-Small Cell Lung Cancer; Renal Cell Cancer

First-In-Human Study For Bispecific Checkpoint Inhibitor Shows ‘Encouraging Activity'

More news

E-Learning

02 Jun 2022

Gastrointestinal Cancers; Immunotherapy; Oesophageal Cancer

ESMO E-Learning: First Line Immunotherapy for Oesophageal and Gastric Cancer as New Standard of Care

Andrés Cervantes , Tania Fleitas Kanonnikoff

27 May 2021

Immunotherapy; Melanoma

ESMO E-Learning: Metastatic Melanoma Treatment

Paolo A. Ascierto

08 Jan 2020

Immunotherapy; Melanoma

ESMO E-Learning: Neoadjuvant Immunotherapy in Melanoma – The Pathway Towards Personalised Immunotherapy

Christian U Blank

07 May 2019

Colon and Rectal Cancer; Gastrointestinal Cancers; Immunotherapy

ESMO E-Learning: Immunotherapy Strategies for Colorectal Cancer

Guillem Argilés

More e-learning modules

Factsheets on Biomarkers

06 Oct 2017

Basic Principles in the Management and Treatment (of cancer); Immunotherapy; Personalised/Precision Medicine; Therapy

Tumour Mutational Load: ESMO Biomarker Factsheet

Nicola Normanno

More factsheets

Meeting resources

ESMO-Virtual-Advanced-Courses-Cancer-Vaccines-Cellular-Immunotheray-1000x1000

ESMO Course

ESMO Virtual Advanced Course on Cancer Vaccines and Cellular Immunotherapy 2022

29 Apr 2022

ESMO Course

ESMO-The Christie Virtual Preceptorship on Lung Cancer March 2022

9 Mar 2022

ESMO Congress

ESMO Immuno-Oncology Congress 2021

8 Dec 2021 Virtual

ESMO Course

ESMO Virtual Preceptorship on Immuno-Oncology 2021

22 Nov 2021 Virtual

ESMO-Virtual-Advanced-Course-on-Liquid-biopsy-1000x1000

ESMO Course

ESMO Virtual Advanced Course on Liquid Biopsy for Cancer Management June 2021

15 Jun 2021

More meeting resources